596
Views
0
CrossRef citations to date
0
Altmetric
Novel Vaccines

Preferences of pregnant women toward a future maternal Group B Streptococcus vaccine in China: A cross-sectional survey with a discrete choice experiment

ORCID Icon, , , ORCID Icon, , & show all
Article: 2281713 | Received 15 Aug 2023, Accepted 03 Nov 2023, Published online: 21 Nov 2023

References

  • Gonçalves BP, Procter SR, Paul P, Chandna J, Lewin A, Seedat F, Koukounari A, Dangor Z, Leahy S, Santhanam S, et al. Group B Streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health. 2022;10(6):e807–10. doi:10.1016/S2214-109X(22)00093-6.
  • Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, Madhi SA, Baker CJ, Bartlett L, Cutland C, et al. Infant Group B Streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S160–S72. doi:10.1093/cid/cix656.
  • Ji W, Liu H, Madhi SA, Cunnington M, Zhang Z, Dangor Z, Zhou H, Mu X, Jin Z, Wang A, et al. Clinical and molecular epidemiology of invasive Group B Streptococcus disease among infants, China. Emerg Infect Dis. 2019;25(11):2021–30. doi:10.3201/eid2511.181647.
  • Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Blencowe H, Cousens S, Baker CJ, et al. Estimates of the burden of Group B Streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis. 2017;65(suppl_2):S200–S19. doi:10.1093/cid/cix664.
  • Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, et al. Epidemiology of invasive early-onset and late-onset Group B Streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 2019;173(3):224–33. doi:10.1001/jamapediatrics.2018.4826.
  • Chinese Medical Association. Chinese experts consensus on prevention of perinatal Group B Streptococcal disease. Chin J Perinat Med. 2021;24:561–6. (In Chinese).
  • Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, Sears MR, Mandhane PJ, Turvey SE, Subbarao P, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. Bjog. 2016;123(6):983–93. doi:10.1111/1471-0528.13601.
  • Le Doare K, O’Driscoll M, Turner K, Seedat F, Russell NJ, Seale AC, Heath PT, Lawn JE, Baker CJ, Bartlett L, et al. Intrapartum antibiotic chemoprophylaxis policies for the prevention of Group B Streptococcal disease worldwide: systematic review. Clin Infect Dis. 2017;65(suppl_2):S143–s51. doi:10.1093/cid/cix654.
  • Pfizer. FDA grants breakthrough therapy designation to Pfizer’s Group B Streptococcus vaccine candidate to help prevent infection in infants via immunization of pregnant women |Business wire. [Online]. [assessed 2022 Sep 25].
  • Oliveira LMA, Simões LC, Costa NS, Zadoks RN, Pinto TCA. The landscape of antimicrobial resistance in the neonatal and multi-host pathogen Group B Streptococcus: review from a one health perspective. Front Microbiol. 2022;13:943413. doi:10.3389/fmicb.2022.943413.
  • Carreras-Abad C, Ramkhelawon L, Heath PT, Le Doare K. A vaccine against Group B Streptococcus: recent advances. Infect Drug Resist. 2020;13:1263–72. doi:10.2147/IDR.S203454.
  • Absalon J, Segall N, Block SL, Center KJ, Scully IL, Giardina PC, Peterson J, Watson WJ, Gruber WC, Jansen KU, et al. Safety and immunogenicity of a novel hexavalent Group B Streptococcus conjugate vaccine in healthy non-pregnant adults: a phase 1/2 randomised placebo-controlled observer-blinded dose-escalation trial. Lancet Infect Dis. 2021;21(2):263–74. doi:10.1016/S1473-3099(20)30478-3.
  • Giles ML, Buttery J, Davey MA, Wallace E. Pregnant women’s knowledge and attitude to maternal vaccination including Group B Streptococcus and respiratory syncytial virus vaccines. Vaccine. 2019;37(44):6743–9. doi:10.1016/j.vaccine.2019.08.084.
  • Geoghegan S, Faerber J, Stephens L, Gillan H, Drew RJ, Eogan M, Feemster KA, Butler KM. Preparing for Group B Streptococcus vaccine. Attitudes of pregnant women in two countries. Hum Vaccin Immunother. 2023;19(1):2195331. doi:10.1080/21645515.2023.2195331.
  • Michaels-Igbokwe C, MacDonald S, Currie GR. Individual preferences for child and adolescent vaccine attributes: a systematic review of the stated preference literature. Patient. 2017;10(6):687–700. doi:10.1007/s40271-017-0244-x.
  • EW de Bekker-Grob, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145–72. doi:10.1002/hec.1697.
  • Quaife M, Terris-Prestholt F, Di Tanna GL, Vickerman P. How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity. Eur J Health Econ. 2018;19(8):1053–66. doi:10.1007/s10198-018-0954-6.
  • Hofman R, de Bekker-Grob EW, Raat H, Helmerhorst TJ, van Ballegooijen M, Korfage IJ. Parents’ preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment. BMC Public Health. 2014;14(1):454. doi:10.1186/1471-2458-14-454.
  • Shono A, Kondo M. Parents’ preferences for seasonal influenza vaccine for their children in Japan. Vaccine. 2014;32(39):5071–6. doi:10.1016/j.vaccine.2014.07.002.
  • Wang X, Feng Y,Zhang Q, Ye L, Cao M, Liu P, Liu S, Li S, Zhang J. Parental preference for haemophilus influenzae type b vaccination in Zhejiang Province China: a discrete choice experiment. Front Public Health. 2022;10:967693. doi:10.3389/fpubh.2022.967693.
  • Poulos C, Reed Johnson F, Krishnarajah G, Anonychuk A,Misurski D. Pediatricians’ preferences for infant meningococcal vaccination. Value Health. 2015;18(1):67–77. doi:10.1016/j.jval.2014.10.010.
  • Madhi SA, Anderson AS, Absalon J, Radley D, Simon R, Jongihlati B, Strehlau R, van Niekerk AM, Izu A, Naidoo N, et al. Potential for maternally administered vaccine for infant Group B Streptococcus. N Engl J Med. 2023;389(3):215–27. doi:10.1056/NEJMoa2116045.
  • Hauber AB, González JM, Groothuis-Oudshoorn CG, Prior T, Marshall DA, Cunningham C, IJzerman MJ, Bridges JFP. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300–15. doi:10.1016/j.jval.2016.04.004.
  • Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, Johnson FR, Mauskopf J. Conjoint analysis applications in health—a checklist: a report of the ispor good research practices for conjoint analysis task force. Value Health. 2011;14(4):403–13. doi:10.1016/j.jval.2010.11.013.
  • Reed Johnson F, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier DA, Bresnahan BW, Kanninen B, Bridges JFP. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13. doi:10.1016/j.jval.2012.08.2223.
  • Marshall D, Bridges JF, Hauber B, Cameron R, Donnalley L, Fyie K, Johnson FR. Conjoint analysis applications in health – how are studies being designed and reported? Patient. 2010;3(4):249–56. doi:10.2165/11539650-000000000-00000.
  • Diks ME, Hiligsmann M, van der Putten IM. Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments. BMC Infect Dis. 2021;21(1):879. doi:10.1186/s12879-021-06398-9.
  • yaozh data. 23-valent pneumococcal polysaccharide vaccine procurement price. 2022.
  • Guiding principles of the national medical products administration of China on the issuance of grading standards for adverse events in clinical trials of vaccines for prophylactic use. National Medical Products Administration; 2019.
  • China Health Statistical Yearbook 2021. National health commission of People’s Republic of China. 2021.
  • Johnson R, Orme B. Getting the most from CBC. Sawtooth Software Research Paper. 2003.
  • Zhu S, Chang J, Hayat K, Li P, Ji W, Fang Y. Parental preferences for HPV vaccination in junior middle school girls in China: a discrete choice experiment. Vaccine. 2020;38(52):8310–7. doi:10.1016/j.vaccine.2020.11.020.
  • Sargazi N, Takian A, Yaseri M, Daroudi R, Ghanbari Motlagh A, Nahvijou A, Zendehdel K. Mothers’ preferences and willingness-to-pay for human papillomavirus vaccines in Iran: a discrete choice experiment study. Prev Med Rep. 2021;23:101438. doi:10.1016/j.pmedr.2021.101438.
  • Balogun FM, Omotade OO, Svensson M. Stated preferences for human papillomavirus vaccination for adolescents in selected communities in Ibadan Southwest Nigeria: a discrete choice experiment. Hum Vaccin Immunother. 2022;18(6):2124091. doi:10.1080/21645515.2022.2124091.
  • Patterson BJ, Myers K, Stewart A, Mange B, Hillson EM, Poulos C. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment. Expert Rev Vaccines. 2021;20(6):729–41. doi:10.1080/14760584.2021.1910502.
  • Jiang M, Li P, Yao X, Hayat K, Gong Y, Zhu S, Peng J, Shi X, Pu Z, Huang Y, et al. Preference of influenza vaccination among the elderly population in Shaanxi province China. Hum Vaccin Immunother. 2021;17(9):3119–25. doi:10.1080/21645515.2021.1913029.
  • Hoogink J, Verelst F, Kessels R, van Hoek AJ, Timen A Willem L, Beutels P, Wallinga J, de Wit GA. Preferential differences in vaccination decision-making for oneself or one’s child in the Netherlands: a discrete choice experiment. BMC Public Health. 2020;20(1):828. doi:10.1186/s12889-020-08844-w.
  • Verelst F, Kessels R, Delva W, Beutels P, Willem L. Drivers of vaccine decision-making in South Africa: a discrete choice experiment. Vaccine. 2019;37(15):2079–89. doi:10.1016/j.vaccine.2019.02.056.
  • Dempsey AF, Pyrzanowski J, Donnelly M, Brewer S, Barnard J, Beaty BL, Mazzoni S, O’Leary ST. Acceptability of a hypothetical Group B strep vaccine among pregnant and recently delivered women. Vaccine. 2014;32(21):2463–8. doi:10.1016/j.vaccine.2014.02.089.
  • McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, et al. Factors influencing women’s attitudes towards antenatal vaccines Group B Streptococcus and clinical trial participation in pregnancy: an online survey. BMJ Open. 2016;6:e010790. doi:10.1136/bmjopen-2015-010790.
  • McQuaid F, Jones C, Stevens Z, Meddaugh G, O’Sullivan C, Donaldson B, Hughes R, Ford C, Finn A, Faust SN, et al. Antenatal vaccination against Group B Streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. Acta Obstet Gynecol Scand. 2018;97(3):330–40. doi:10.1111/aogs.13288.
  • Campbell D, Erdem S. Including opt-out options in discrete choice experiments: issues to consider. Patient. 2019;12(1):1–14. doi:10.1007/s40271-018-0324-6.
  • Veldwijk J, Lambooij MS, EW de Bekker-Grob, Smit HA, de Wit GA. The effect of including an opt-out option in discrete choice experiments. PLoS One. 2014;9(11):e111805. doi:10.1371/journal.pone.0111805.